New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

M Silingardi - Italian Journal of Medicine, 2013 - italjmed.org
Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …
被引用次数：1 相关文章

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

M Silingardi - Italian Journal of Medicine, 2013 - italjmed.org
Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …
[PDF] semanticscholar.org

[PDF][PDF] New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

M Silingardi - Italian Journal of Medicine, 2013 - pdfs.semanticscholar.org
Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …
[PDF] archive.org

[PDF][PDF] New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

M Silingardi - Italian Journal of Medicine, 2013 - scholar.archive.org
Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

M Silingardi - Italian Journal of Medicine, 2013 - italjmed.org
Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …